abstract |
The use of at least one strain of lactic bacteria and/or its metabolites or a medium fermented by at least one lactic bacteria that have been isolated and selected for its ability to display a strong anti-Helicobacter bactericidal activity in vitro, for the preparation of a composition intended for the prophylaxis or the treatment of disorders related to GHLOs infection in pets and pet food compositions containing same. |